Purpose
To develop a candidate vaccine that can be advanced to clinical testing that elicits neutralizing antibodies against HIV, particularly the V3 glycan target.
Grantee
Division
Global Health
Date
JULY 2025
Region served
GLOBAL
Committed amount
$4,000,000
Grant topic
HIV
Duration (months)
35
Grantee location
Pasadena, California, United States
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.